Crunching the numbers for LLY... Refresh in a moment for the full analysis.
ELI LILLY & Co (LLY)
Healthcare
Deep Overvalued
mixed
$946.76
Updated: 2026-04-12
59
TradeApes Score
hold
Financial Strength
60
Healthy
Operating Trend
75
Strong
Valuation
40
Weak
Capital Allocation
45
Mixed
Risk
80
Strong
Fair Value
$0.0
Sector Rank
#16
of 16
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
High P/E — 25–45×, growth premium already priced in
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.